Replies to post #290707 on NorthWest Biotherapeutics Inc (NWBO)

[anders2211]

I have a hunch that NWBO may have underestimated the time it would take to complete the IDH mutation work. The decision to identify those patients with the IDH1 mutation and those with the wild type most probably was taken sometimes after February 18, the day the April 18 ASM meeting was announced.

I think you are absolutely right

I have repeatedly said here that NWBO has underestimated the work. IMO due to the lack of knowledge sitting with NWBO.

I would certainly hope that NWBO on June 2 had learned how incredibly difficult the IDH1 mutation work really is and the 2-3 weeks estimate was a truly educated estimate and not a throw the head up in the air.